2025
Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment
Sperduto P, Marqueen K, Chang E, Li J, Davies M, Ebner D, Breen W, Lamba N, Shih H, Edwards D, Kim M, Mahal A, Rahman R, Ankrah N, Boggs D, Lewis C, Hyer D, Buatti J, Johri F, Soliman H, Masucci L, Roberge D, Aneja S, Chiang V, Phuong C, Braunstein S, Dajani S, Sachdev S, Wan Z, Niedzwiecki D, Vaios E, Kirkpatrick J, Pasetsky J, Wang T, Kutuk T, Kotecha R, Ross R, Rusthoven C, Nakano T, Tawbi H, Mehta M. Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment. Journal Of Clinical Oncology 2025, 43: 1910-1919. PMID: 40245362, PMCID: PMC12119226, DOI: 10.1200/jco-24-01351.Peer-Reviewed Original ResearchConceptsGraded Prognostic AssessmentMelanoma brain metastasesPrognostic factorsPrognostic assessmentAbsence of extracranial metastasesGPA 0Multi-institutional retrospective databaseTreatments associated with survivalAnalysis of prognostic factorsMedian follow-up timeModern multimodality therapyKarnofsky performance statusClinical trial eligibilityBrain metastasesExtracranial metastasesMedian survivalMelanoma patientsMultimodal therapyPerformance statusMultidisciplinary treatmentImproved survivalRetrospective databaseTrial eligibilityTherapeutic modalitiesClinical trials
2020
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today
Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto W, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, Yu J, Chiang V, Nakano T, Aoyama H, Mehta MP. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. International Journal Of Radiation Oncology • Biology • Physics 2020, 107: 334-343. PMID: 32084525, PMCID: PMC7276246, DOI: 10.1016/j.ijrobp.2020.01.051.Peer-Reviewed Original ResearchConceptsDiagnosis-specific prognostic factorsHuman epidermal receptor 2Prognostic factorsMedian survivalBreast-GPABrain metastasesBreast cancerCohort BCohort APrognostic indexReceptor 2Tumor subtypesBreast cancer brain metastasesKaplan-Meier survival estimatesCancer brain metastasesGraded Prognostic AssessmentKarnofsky performance statusLarge contemporary cohortLog-rank testFuture clinical trialsNew prognostic factorsGPA 0Extracranial metastasesPerformance statusBetter prognosis
2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP. Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA). Clinical And Translational Radiation Oncology 2019, 18: 39-45. PMID: 31341974, PMCID: PMC6612649, DOI: 10.1016/j.ctro.2019.06.007.Peer-Reviewed Original ResearchDiagnosis-Specific Graded Prognostic AssessmentBrain metastasesMedian survivalGastrointestinal cancerPrognostic factorsPrognostic assessmentGI cancer patientsOverall median survivalGraded Prognostic AssessmentMultiple Cox regressionFuture clinical trialsMulti-national cohortWorst prognostic groupLarge contemporary databaseGPA 0Hazard ratioCox regressionGI cancersPrognostic groupsCancer patientsClinical trialsIndividual patientsTherapy selectionPatientsFirst treatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply